| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Katharina Schallmoser | Q50648053 |
| Eva Rohde | Q51471409 | ||
| P2093 | author name string | Sandra Laner-Plamberger | |
| Mario Gimona | |||
| Karin Pachler | |||
| P2860 | cites work | The Biodistribution and Immune Suppressive Effects of Breast Cancer-Derived Exosomes | Q88589743 |
| Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome | Q24548495 | ||
| A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer | Q24796746 | ||
| Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial | Q24801506 | ||
| Changing R&D; models in research-based pharmaceutical companies | Q26749511 | ||
| Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes | Q27317206 | ||
| Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts | Q27349234 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Stem cell-derived exosomes as a therapeutic tool for cardiovascular disease | Q28071466 | ||
| Peripheral blood mononuclear cell secretome for tissue repair | Q28071643 | ||
| Towards Therapeutic Delivery of Extracellular Vesicles: Strategies for In Vivo Tracking and Biodistribution Analysis | Q28075450 | ||
| Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury | Q28272621 | ||
| Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration | Q28273038 | ||
| Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes | Q29619437 | ||
| Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 | Q29620590 | ||
| Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper | Q30360749 | ||
| MicroRNA miR-133b is essential for functional recovery after spinal cord injury in adult zebrafish | Q30500389 | ||
| Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells | Q30596875 | ||
| Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters | Q30650963 | ||
| Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus. | Q33620044 | ||
| Fracture healing is accelerated in the absence of the adaptive immune system. | Q33635563 | ||
| Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease | Q33722420 | ||
| Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta | Q33855709 | ||
| Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles | Q34026858 | ||
| Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth | Q34275817 | ||
| Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles | Q34455456 | ||
| TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo. | Q34601443 | ||
| Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs | Q34611079 | ||
| Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification | Q34660939 | ||
| Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs | Q34999840 | ||
| Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine | Q35064686 | ||
| CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA. | Q35158953 | ||
| Harnessing and modulating inflammation in strategies for bone regeneration. | Q35570026 | ||
| Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy | Q39111448 | ||
| Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection | Q39170295 | ||
| Pharmacokinetics of Exosomes-An Important Factor for Elucidating the Biological Roles of Exosomes and for the Development of Exosome-Based Therapeutics. | Q39173469 | ||
| Academic, Foundation, and Industry Collaboration in Finding New Therapies | Q39280739 | ||
| Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions | Q40110835 | ||
| Size-Exclusion Chromatography-based isolation minimally alters Extracellular Vesicles' characteristics compared to precipitating agents. | Q41117495 | ||
| Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey | Q41643859 | ||
| A recoverable state of axon injury persists for hours after spinal cord contusion in vivo. | Q41686038 | ||
| Combining mesenchymal stem cell sheets with platelet-rich plasma gel/calcium phosphate particles: a novel strategy to promote bone regeneration | Q41820549 | ||
| Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa | Q47093569 | ||
| Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation. | Q48448566 | ||
| The secretome of apoptotic human peripheral blood mononuclear cells attenuates secondary damage following spinal cord injury in rats. | Q50449621 | ||
| Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles. | Q50739898 | ||
| HucMSC-Exosome Mediated-Wnt4 Signaling Is Required for Cutaneous Wound Healing. | Q51072021 | ||
| Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. | Q51259639 | ||
| Osteogenic potential of injectable tissue-engineered bone: a comparison among autogenous bone, bone substitute (Bio-oss), platelet-rich plasma, and tissue-engineered bone with respect to their mechanical properties and histological findings. | Q51539975 | ||
| Translational research for injectable tissue-engineered bone regeneration using mesenchymal stem cells and platelet-rich plasma: from basic research to clinical case study. | Q51603519 | ||
| HucMSC Exosome-Delivered 14-3-3ζ Orchestrates Self-Control of the Wnt Response via Modulation of YAP During Cutaneous Regeneration. | Q51687594 | ||
| Production and characterization of clinical grade exosomes derived from dendritic cells. | Q53664068 | ||
| Immunomodulatory effects of mesenchymal stromal cells-derived exosome. | Q53989481 | ||
| Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis--a preliminary result of three cases | Q80799478 | ||
| Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer | Q80944857 | ||
| Anti-inflammatory Mechanism of Bone Marrow Mesenchymal Stem Cell Transplantation in Rat Model of Spinal Cord Injury | Q85945631 | ||
| MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease | Q87134152 | ||
| An FDA perspective on preclinical development of cell-based regenerative medicine products | Q87507600 | ||
| Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. | Q35594874 | ||
| Heparin affinity purification of extracellular vesicles | Q35623385 | ||
| Exosome-mediated inflammasome signaling after central nervous system injury | Q35894055 | ||
| Immune modulation as a therapeutic strategy in bone regeneration | Q35985907 | ||
| Translating stem cell research to the clinic: a primer on translational considerations for your first stem cell protocol | Q35986917 | ||
| Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression | Q36067866 | ||
| Adult bone marrow mesenchymal and neural crest stem cells are chemoattractive and accelerate motor recovery in a mouse model of spinal cord injury | Q36247199 | ||
| Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. | Q36422761 | ||
| Chromatographically isolated CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI | Q36459432 | ||
| Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivo | Q36615664 | ||
| Cells release subpopulations of exosomes with distinct molecular and biological properties | Q36638253 | ||
| Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. | Q36666328 | ||
| Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. | Q36734451 | ||
| Extracellular vesicle isolation and characterization: toward clinical application | Q36737951 | ||
| Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. | Q36821101 | ||
| Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production | Q37170068 | ||
| MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles | Q37209961 | ||
| Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane | Q37414734 | ||
| Exosomes from Human Umbilical Cord Mesenchymal Stem Cells: Identification, Purification, and Biological Characteristics | Q37571844 | ||
| Exosomes Secreted from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Osteonecrosis of the Femoral Head by Promoting Angiogenesis | Q37675908 | ||
| Establishing criteria for human mesenchymal stem cell potency | Q37718020 | ||
| Extracellular Vesicle-functionalized Decalcified Bone Matrix Scaffolds with Enhanced Pro-angiogenic and Pro-bone Regeneration Activities | Q37734819 | ||
| Extracellular vesicles: biology and emerging therapeutic opportunities. | Q38098874 | ||
| Emerging role of extracellular vesicles in inflammatory diseases. | Q38188861 | ||
| A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles | Q38236850 | ||
| Concise Review: MSC-Derived Exosomes for Cell-Free Therapy | Q38432643 | ||
| Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles. | Q38543841 | ||
| MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA. | Q38674894 | ||
| Stem Cell Extracellular Vesicles: Extended Messages of Regeneration | Q38798555 | ||
| Exosomes derived from mineralizing osteoblasts promote ST2 cell osteogenic differentiation by alteration of microRNA expression | Q38804007 | ||
| Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine | Q38894992 | ||
| Benchtop isolation and characterization of functional exosomes by sequential filtration. | Q38933810 | ||
| Extracellular Vesicle-Shuttled mRNA in Mesenchymal Stem Cell Communication. | Q38977480 | ||
| Mesenchymal stem cells secrete immunologically active exosomes | Q39039982 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | extracellular vesicle | Q21097485 |
| cell | Q7868 | ||
| biomedical investigative technique | Q66648976 | ||
| P577 | publication date | 2017-06-03 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use. | |
| P478 | volume | 18 |
| Q92876640 | Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration |
| Q92816008 | Advances in Analysis of Biodistribution of Exosomes by Molecular Imaging |
| Q64080425 | Conditioned Medium from Human Mesenchymal Stromal Cells: Towards the Clinical Translation |
| Q64081582 | Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications |
| Q92988149 | Differential Effects of Extracellular Vesicles of Lineage-Specific Human Pluripotent Stem Cells on the Cellular Behaviors of Isogenic Cortical Spheroids |
| Q89818309 | Differential fluorescence nanoparticle tracking analysis for enumeration of the extracellular vesicle content in mixed particulate solutions |
| Q89748333 | Diffusion and transport of extracellular vesicles |
| Q90236424 | Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles |
| Q91283827 | Exosomes - beyond stem cells for restorative therapy in stroke and neurological injury |
| Q49670220 | Exosomes in Extracellular Matrix Bone Biology. |
| Q88884606 | Exosomes in Myocardial Repair: Advances and Challenges in the Development of Next-Generation Therapeutics |
| Q89493321 | Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation |
| Q92571669 | Extracellular Vesicles as a Potential Therapy for Neonatal Conditions: State of the Art and Challenges in Clinical Translation |
| Q55461485 | Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers. |
| Q55386177 | Generation and testing of clinical-grade exosomes for pancreatic cancer. |
| Q93136005 | Human ES-derived MSCs correct TNF-α-mediated alterations in a blood-brain barrier model |
| Q47236063 | Human Neural Stem Cell Extracellular Vesicles Improve Tissue and Functional Recovery in the Murine Thromboembolic Stroke Model |
| Q95269606 | ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential therapeutic agents to suppress COVID-19 |
| Q52338857 | Imaging of extracellular vesicles derived from human bone marrow mesenchymal stem cells using fluorescent and magnetic labels. |
| Q90700357 | Lipidomics and RNA sequencing reveal a novel subpopulation of nanovesicle within extracellular matrix biomaterials |
| Q90617296 | Mesenchymal Stem Cell-Derived Extracellular Vesicles in Tissue Regeneration |
| Q91899785 | Mesenchymal Stromal Cell-Based Bone Regeneration Therapies: From Cell Transplantation and Tissue Engineering to Therapeutic Secretomes and Extracellular Vesicles |
| Q92735596 | Mesenchymal stem cell-derived exosomes for clinical use |
| Q98726614 | Mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles: Potential roles in rheumatic diseases |
| Q59350192 | Neural stem cell derived extracellular vesicles: Attributes and prospects for treating neurodegenerative disorders |
| Q47148827 | Non-coding RNAs in Mesenchymal Stem Cell-Derived Extracellular Vesicles: Deciphering Regulatory Roles in Stem Cell Potency, Inflammatory Resolve, and Tissue Regeneration. |
| Q91808750 | Noninvasive Assessment of Exosome Pharmacokinetics In Vivo: A Review |
| Q95840447 | RNA delivery by extracellular vesicles in mammalian cells and its applications |
| Q99638721 | Research progress on exosomes derived from mesenchymal stem cells in hematological malignancies |
| Q64102230 | Roles of Exosomes Derived From Immune Cells in Cardiovascular Diseases |
| Q64942363 | Stem Cell Extracellular Vesicles in Skin Repair. |
| Q99565647 | Systematic review of extracellular vesicle-based treatments for lung injury: are EVs a potential therapy for COVID-19? |
| Q92593930 | The potential roles of stem cell-derived extracellular vesicles as a therapeutic tool |
| Q48162156 | Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes |
Search more.